CTT Pharmaceutical Holdings, Inc. (CTTH) stock
CTTHOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2015, quarter ended Sep 30, 2015Last filing: 10-Q on Nov 18, 2026
$0.06−0.00 (-0.17%)
Close on Oct 16, 2026Market cap $1.26MP/E –Yield –
CTT Pharmaceutical pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
CTT Pharmaceutical's pe ratio was 44.0× on Apr 30, 2012.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2012 | Apr 30, 2012 | 44.0× | −240.4 |
| 2011 | Dec 30, 2011 | 284.4× | – |
See a number that looks wrong?